137 related articles for article (PubMed ID: 18923437)
1. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
Graux C; Stevens-Kroef M; Lafage M; Dastugue N; Harrison CJ; Mugneret F; Bahloula K; Struski S; Grégoire MJ; Nadal N; Lippert E; Taviaux S; Simons A; Kuiper RP; Moorman AV; Barber K; Bosly A; Michaux L; Vandenberghe P; Lahortiga I; De Keersmaecker K; Wlodarska I; Cools J; Hagemeijer A; Poirel HA; ;
Leukemia; 2009 Jan; 23(1):125-33. PubMed ID: 18923437
[TBL] [Abstract][Full Text] [Related]
2. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
Graux C; Cools J; Melotte C; Quentmeier H; Ferrando A; Levine R; Vermeesch JR; Stul M; Dutta B; Boeckx N; Bosly A; Heimann P; Uyttebroeck A; Mentens N; Somers R; MacLeod RA; Drexler HG; Look AT; Gilliland DG; Michaux L; Vandenberghe P; Wlodarska I; Marynen P; Hagemeijer A
Nat Genet; 2004 Oct; 36(10):1084-9. PubMed ID: 15361874
[TBL] [Abstract][Full Text] [Related]
3. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
Hagemeijer A; Graux C
Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
[TBL] [Abstract][Full Text] [Related]
4. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
5. Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.
Stergianou K; Fox C; Russell NH
Leukemia; 2005 Sep; 19(9):1680-1. PubMed ID: 16015385
[No Abstract] [Full Text] [Related]
6. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
[TBL] [Abstract][Full Text] [Related]
7. ABL1 fusions in T-cell acute lymphoblastic leukemia.
De Keersmaecker K
Verh K Acad Geneeskd Belg; 2008; 70(4):245-55. PubMed ID: 19166098
[TBL] [Abstract][Full Text] [Related]
8. A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia.
van Vlierberghe P; Meijerink JP; Lee C; Ferrando AA; Look AT; van Wering ER; Beverloo HB; Aster JC; Pieters R
Leukemia; 2006 Jul; 20(7):1245-53. PubMed ID: 16673019
[TBL] [Abstract][Full Text] [Related]
9. ABL1 amplification in T-cell acute lymphoblastic leukemia.
Bernasconi P; Calatroni S; Giardini I; Inzoli A; Castagnola C; Cavigliano PM; Rocca B; Boni M; Quarna J; Zappatore R; Caresana M; Bianchessi C; Pallavicini EB; Lazzarino M
Cancer Genet Cytogenet; 2005 Oct; 162(2):146-50. PubMed ID: 16213363
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract][Full Text] [Related]
11. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.
Quintás-Cardama A; Tong W; Manshouri T; Vega F; Lennon PA; Cools J; Gilliland DG; Lee F; Cortes J; Kantarjian H; Garcia-Manero G
Leukemia; 2008 Jun; 22(6):1117-24. PubMed ID: 18401417
[TBL] [Abstract][Full Text] [Related]
12. Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Graux C; Marynen P; Maertens J; Cools J; Vandenberghe P
Leukemia; 2006 Dec; 20(12):2202-4. PubMed ID: 17024111
[No Abstract] [Full Text] [Related]
13. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
14. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
Ballerini P; Busson M; Fasola S; van den Akker J; Lapillonne H; Romana SP; Marynen P; Bernard OA; Landman-Parker J; Berger R
Leukemia; 2005 Mar; 19(3):468-70. PubMed ID: 15674415
[No Abstract] [Full Text] [Related]
15. NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
Burmeister T; Gökbuget N; Reinhardt R; Rieder H; Hoelzer D; Schwartz S
Blood; 2006 Nov; 108(10):3556-9. PubMed ID: 16873673
[TBL] [Abstract][Full Text] [Related]
16. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
Van Limbergen H; Beverloo HB; van Drunen E; Janssens A; Hählen K; Poppe B; Van Roy N; Marynen P; De Paepe A; Slater R; Speleman F
Genes Chromosomes Cancer; 2001 Mar; 30(3):274-82. PubMed ID: 11170285
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions.
Papenhausen P; Kelly CA; Zhang Z; Tepperberg J; Burnside RD; Schwartz S
Cancer Genet; 2019 Feb; 231-232():1-13. PubMed ID: 30803551
[TBL] [Abstract][Full Text] [Related]
19. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
[TBL] [Abstract][Full Text] [Related]
20. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
